Intermittent Claudication

Use of Guideline-Recommended Tx Low in PAD Patients

May 03, 2017

Increased odds of antiplatelet therapy, statins, ACEI/ARB, smoking counseling with comorbid CAD

Impact of Pentoxifylline on BP, Inflammatory Markers

By August 16, 2016

Pentoxifylline did not alter blood pressure or plasma IL-6 concentration but did significantly decrease circulating TNF-α and C-reactive protein (CRP) concentrations, a study in the Journal of Hypertension reported.

Combo Tx Ups Benefits in Intermittent Claudication

November 11, 2015

Greater improvements in waking distances, quality of life with revascularization plus exercise.

Is Cilostazol More Effective Than Pentoxifylline for Intermittent Claudication with PAD?

November 03, 2014

A review in the Cochrane Library evaluated 15 double-blind, randomized-controlled trials of cilostazol vs. placebo or other antiplatelet agents on improving initial and absolute claudication distances and in reducing mortality and vascular events in patients with stable intermittent claudication.

Aspirin and Clopidogrel Improve Claudication Distance

February 23, 2012

In patients with stable intermittent claudication due to peripheral arterial disease, low-dose aspirin appears to work as well as clopidogrel when given in conjunction with walking rehabilitation to improve initial claudication distance (ICD) and absolute claudication distance (ACD).